CAR-engineered NK cells are remarkable to CAR-T cells; they seem like safer given that they do not induce cytokine release syndrome (CRS) and so they engage various mechanisms to promote cytotoxicity188. Additionally they lend by themselves to ‘off-the shelf’ manufacturing, that's, they can be generated from peripheral blood cells or https://www.directivepublications.org/journal-of-clinical-breast-cancer/